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Abstract:
for tissue engineering structures based on their physiological conditions. Comprehensive physiological requirements in both
micro and macro scales were considered in developing the optimisation design for complex vascular vessels. The optimised
design was then manufactured by stereolithography process using materials that are biocompatible, elastic and surface
bio-coatable. The materials are self-developed photocurable resin consist of BPA-ethoxylated-diacrylate, lauryl acrylate
and isobornylacrylate with Irgacure® 184, the photoinitiator. The optimised vascular vessel offers many advantages: 1) it
provides the maximum nutrient supply; 2) it minimises the recirculation areas and 3) it allows the wall shear stress on the
vessel in a healthy range. The stereolithography manufactured vascular vessels were then embedded in the hydrogel seeded
with cells. The results of in vitro studies show that the optimised vascular network has the lowest cell death rate compared
with a pure hydrogel scaffold and a hydrogel scaffold embedded within a single tube in day seven. Consequently, these
design and manufacture routes were shown to be viable for exploring and developing a high range complex and specialised
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1. Introduction
Successfully producing full skin models with an overall
thickness of several millimetres is a significant goal in
skin tissue engineering. Full skin models can be used
as implants or grafts to replace damaged skin or used to
reduce and replace animal testing in the pharmaceutical
industry[1,2]
full thickness skin models is that the artificial skin
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needs to develop adequate vascularisation for long-term
survival[3]. Without a functional vascular network, the
diffusion of oxygen is limited to a distance of 100–200
microns[4]. This can be addressed by pre-embedding
an artificial vascular network into the skin scaffolds.
The embedded network has two primary functions:
1) to supply nutrients and other soluble factors and
remove waste products from the surrounding cells and
2) to develop small sprouting capillaries that can be
connected with existing blood vessels, also known as
angiogenesis[5-8]. Nutrition supply in the human body
is realized by a very complex blood vessel network.
It consists of vessels in dimensions between several
millimetres down to several micrometres in diameter.
needed. Traditional manufacturing technologies, such
as spinning, dip-coating or extrusion, can produce linear
tubes with different inner-diameters[9]. However, it is not
possible to generate branched vessels, with decreasing
or increasing internal diameters to mimic the natural
changes in blood vessel networks.
With Additive Manufacturing (AM), three-dimensional
(3D) objects can be produced from 3D computer-aided
design (CAD) data by joining materials together using
a layer-by layer manner. It is been employed widely
in fabricating scaffolds and complete constructions
for tissue engineering applications. There are many
AM techniques served as bioprinting systems, such as
microvalve-based, ink-jetting based, extrusion-based
and stereolithography (SLA)-based techniques[10,11]. The
use of these AM technologies will enable the generation
and mimicking of complex blood vessel networks under
controlled conditions. It offers the freedom to design a
vascular network. Currently, some research groups have
successfully constructed and tested branched vascular
vessels[5,12–16]. Wu et al.[14] used fugitive inks to print solid
template within the substrate and then removed the ink to
create microchannels. Hinton et al.[17] invented a freeform
reversible embedding of suspended hydrogels method
(called FRESH in their paper) to print hydrated materials
which enable printing of complex vascular architectures.
However, in their work, vascular networks were printed
with little understanding of the physiological demands.
There is currently a lack of detailed and validated
skin scaffolds.
In our previous work[18,19],  a  set  of design rules were
developed for designing one single artificial vascular
branch made by 3D printing. This paper focuses on
vascular networks based on multiscale physiological
demands. At the microscale, the local bifurcation design
needs to ensure that  the shear stress on the vessel  wall
is in the healthy range. The wall shear stress (WSS) is a
critical hemodynamic indicator that affects endothelial
cell development [20–23]. WSS outside the normal
range between 1Pa to 7Pa[24] is considered harmful to
vessel development and may lead to cardiovascular
diseases[20,25,26]. Many researchers have found that the
branching angles have a significant effect on WSS
in the bifurcation of a branch vessel [27–31].  Another
physiological requirement at the micro-scale is to ensure
minimal recirculation areas where nutrient and oxygen
may be trapped. At the macro-scale, the main objective
of the design is to maximise the nutrient supply and the
waste exchange to surrounding tissues and cells. This
needs to be minimized to use minimal energy supplying
to cover the greatest area of the skin patch to achieve
a satisfactory and uniform nutrient supply. While
the final design will be limited to a two-dimensional
geometry; it could be converted to enable 3D structures
by stacking repeated copies. The optimized vascular
network will be then constructed using SLA. SLA has
advantages in printing micro vascular vessel networks
due to 1) its high resolution, 2) its ability to produce
photocurable resin used in the project has advantages
of elasticity, biocompatibility and surface readiness for
“bio-coatability”. Preliminarily physical validations
were carried out in vitro to show that the optimised
scaffold. Though further in vitro investigation is needed
to provide systematic results, the work presented in this
paper provides significant results to tissue engineering
researchers. Together with previous studies, a complete
network has been fully developed and preliminarily
tested.
2. Design Rules of Vascular Network
Previous design approaches to optimise a vascular
network have been based on the minimisation of the
sum of the energy required for pumping blood through
the network and the energy required for the metabolic
supply of the blood volume. To minimize the energy,
Murray’s law is applied[32,33]:
                            (1)
Using Murray’s law, the radii of daughter vessels
(Rd1 and Rd2) can be obtained based on the radius of
their parent vessels (Rp). It has been confirmed that
most natural vascular systems follow Murray’s law[34]. A
volume minimisation routine was applied in the design
method to determine the position of the branching point.
These technologies were used recently by researchers
to generate different vascular systems[35,36].  However,
several issues were not considered in their research due
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to the restrictions imposed by the traditional method used
to manufacture the artificial vascular vessels. Firstly,
the branches were created using straight tubes, and the
vascular branching design was missing. The second
issue is that nutrient diffusion through the vessel wall to
the surrounding cells was not considered in their design.
Unlike previous attempts, the application of 3D printing
enables arbitrary vascular system design. In this work,
we addressed these issues by developing comprehensive
to be embedded in tissue-engineered skin models.
  The main parameters considered in our design
can be described in two categories: 1) the macro-
scale parameters and 2) the micro-scale parameters.
The macro-scale parameters include branch levels and
branching point locations. The micro-scale parameters
include branch angles, vessel diameters, the daughter
vessel asymmetry ratio, the wall shear stress and the
recirculation areas. Their definition and illustration are
shown in Figure 1.
In Figure 1(A), branch levels and branching point
are illustrated while Figure 1(B) demonstrates parent
diameter Rp , daughter diameters Rd1 and Rd2, total
branching angle , blood velocity , viscosity , density
 and WSS  and the recirculation areas. In the following
sub-sections, developing the design methodology at both
scales is the main objective.
2.1 The macro-scale design (vascular system
First of all, in this design, we focused on bifurcations
because, in normal vasculature, around 98% of blood
vessels bifurcate at each junction, while only 2%
trifurcate[22,37].  We also limit  our design to a 2D plane.
3D structures can be formed by stacking some 2D
vascular systems. The locations of the branching points
are evenly distributed on the skin patch, which can be
illustrated in Figure 2.
Figure 1.  The macro-scale (A) and the micro-scale (B
(A
(B)The micro-scale parameters in the design of one single branching area
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                                           (A)                                                             (B)                                                              (C)
Figure 2. A) 2 levels, B) 3 levels and C) 4 levels.
The position of a point  belonging to the th branching
level and being the th on it are given by the equation
below:
                                                                                     (2)
where, A is the width of the skin patch, B is the length
[38],
which minimised the volume of the vascular system. It
also shows less agglomeration close to the branching
points. The pressure drop at each branching point in the
same level is set to be identical:
                                  (3)
Equations (4) and (5) are derived from equations (1–3)
which enable the calculation of the length and the radius
of each vessel in the vascular system, respectively:
               (4)
  (5)
As the main function of the artificial vascular
network is supplying the tissue and cells with nutrients
and removing metabolic products nutrient diffusion
performance into the area between vessels is a
determining design factor. Fick’s law and Michaelis-
Menten kinetics were applied to investigate the nutrient
diffusion and cell consumption performance of the
                            (6)
where D
is selected as , C is the concentration
of the nutrient,  is a characteristic metabolic time which
is depend on cells. Experimental studies[39] show that
the metabolic rate of glucose in adipose tissue is around
500 s and in skeletal muscle is approximately 545 s.
combined in a characteristic length called “penetration
depth”
                                   (7)
                                                                                  (8)
where  is the volume of the skin model occupied
by living cells while is  the total volume of the skin
model. The total volume is composed of the volume
occupied by the blood vessel system (i.e.  there  is  a
“penalty” for the performance if a complex (i.e. large)
vessel system is used), the volume of the substrate
which is sufficiently supplied by nutrients, and the
volume  which does not provide enough nutrients
to the cells in order to survive. The threshold glucose
concentration  which needs to be reached to supply
cells adequately was set to  = 2.2 mM. Below this
concentration, severe symptoms of hypoglycaemia occur.
Finite difference method was used to solve the equation
(6). In this work, we obtained a diagram illustrating the
relationship between performance  and the penetration
depth  for different levels of vascular vessels, shown
in Figure 3.
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Figure 3. Comparison of performance P of a 5mm wide patch for
the branching levels from 0 to 3.
Figure 4.
In Figure 3, two conclusions can be made. Firstly, the
value of performance P obtained from the distributed
configuration is larger than that in the Kamiya
configuration. Secondly, a higher-level configuration
has a larger P using the same penetration depth. Based
on this, it is possible to select the “least complex”
vessel system, which is necessary to achieve the optimal
performance. A three-level distributed configuration
was therefore determined and it is at least complex and
relatively high performance. The first configuration
sketch of the vascular system is shown in Figure 4.
2.2 Micro-scale design
Endothelial cells are programmed to respond to
mechanical stimulation[24–26]. Endothelial cells in vivo
are typically exposed to, and presumably adapted to,
a normal level of shear stress in the range of 1 Pa to
7 Pa[24]. The endothelial stimulation theory says that
when the WSS is higher than 7 Pa, it can damage the
endothelial cells during vascular remodelling while a
mechanical stimulation on endothelial cells[24]. Therefore,
the local geometry optimisation will take place based on
the endothelial stimulation theory.
According to Khamassi et al.[40], the WSS in a vascular
bifurcation is related to two local parameters. They
are R+, the asymmetry ratio and , the total bifurcation
 is shown in Figure 1(B) and R+
is calculated using equation (9):
                                  (9)
Khamassi et al.[40] established a CFD simulation to
analyse how  and R+ effect the minimal WSS at
bifurcation junctions. They also generated a diagram
to explain their correlations. This diagram is used as
a guide for selecting the bifurcation angles shown in
Figure 5.
In Figure  5, the circles represent the founding WSS
using different combinations of R+ and . The contour
lines in Figure  5 demonstrate the interpolated WSS
values based on the founding values. A distinct optimum
appears when R+
is shown as a square in Figure 5. This diagram suggests
that the branch angle and the asymmetry are the major
geometry parameters of physiological bifurcations.
The selection of bifurcation angle and the asymmetry
should be in the range of the contour lines to lead to a
proper function: the bifurcation angle ranges from 60°
to 140° while the asymmetry ratio ranged from 0.6 to 1.
Previous vascular optimisations did not consider WSS.
The presented design rules for vascular bifurcations
addressed this shortage. In the first version of the
vascular system, we checked all the bifurcation angles
and the asymmetry and found out that two bifurcation
angles are out of the range. An algorithm was then
In Figure 7(A), the farthest branch angles in the third
branching level are out of the range discussed in Figure 5,
which are circled. The correction algorithm is shown in
Figure 6. The main idea is to add another turning point
to achieve a moderate branching and turning. In Figure 6,
the two red margins are the boundaries of the skin patch.
The original branches in level 3 are marked as l0 and l1.
The algorithm is described as following 6 steps:
Step 1: Choose a small value of , and then
calculate angles  and ;
Step 2:  until  and
;
Step 3: get the “new point”; if the new point is inside
the patch, go to step 4; else go to Step 5;
Step 4: Update the diameters of these new vessels
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using according to equation (5);
Step 5: Get a new l0and l1 (dashed lines in Figure 6),
then go to step 1;
Step 6: End of the algorithm.
By applying this algorithm, an update vascular system
is shown in Figure 7(B).
From Figure 7(A), it is shown that sharp junctions
are used in all bifurcation points. These sharp apices
at junctions of bifurcated vessels need to be avoided
because they are considered as risk factors for local
mechanical weakness[23]. Rounding the apex at each
junction can be one of the solutions. The authors
developed an algorithm of computational geometry for
the construction of vascular branches using a rounded
apex[18,19]. CFD simulations were also carried out to test
the design and they concluded that rounded junctions
in the bifurcation branch result in a more uniform WSS
distribution compared to sharp junctions. They also
concluded that the construction generated using their
algorithm will minimise the recirculation area and
thus minimise the trapped nutrient and oxygen. This
algorithm was applied to employ rounded junctions
instead  of  sharp  joints.  the  STL file  of  the  vascular
system will also be generated automatically[18,19] using
this algorithm.
2.3 The design summary and the porous vessel
wall generation
To optimise a vascular network embedded in the skin
patch to supply tissues and cells nutrient and oxygen,
exchange waste and to support angiogenesis, we
considered the design criteria in both macro-scale and
micro-scale.  It can be described as four criteria, which
are:
(a)To maximise the nutrient supply and waste
exchange
(c)To ensure the shear stress on the vessel  wall  is  in
the healthy range
(d)To avoid the blood recirculation.
Using the methodology discussed in sections 2.1 and
2.2; these four criteria can be achieved. Additionally,
the final construction of the vascular system is easy
to transfer to the STL file format. Actual blood vessel
walls are of a semi-permeable material, and thus enable
diffusion of nutrients, oxygen, waste products and CO2,
from and to the blood flow. This function is however
techniques. Instead, our proposed solution aims to enable
the diffusion through engineered pores in the vascular
walls. Because of the limited spatial resolution and
relatively slow build-up time offered by AM equipment,
direct manufacturing of capillaries with smaller
diameters (< 10 µm) is infeasible. The pores were also
designed to enable angiogenesis – the natural generation
and growth of new vessels out of the vessel pores. This
approach allows the smaller capillaries to extend where
Figure 5. WSS as a function of the bifurcation geometry.
Figure 6. The correction algorithm
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Figure 7. the new version of the vascular system
they are needed the most. The pore diameters were
engineered to maximise the diffusion rate (yielding a
lower pore diameter bound for pore radii range), support
angiogenesis, enable steady blood circulation inside the
vessels and maintain their manufacturability via AM
system (yielding an upper pore diameter boundary). The
conical pores were selected with larger outer diameter
pore diameter and smaller inner diameter. This type of
pore leads to a reduction of the pore diameter without
the formation of membranes. The design of the conical
pore is shown in Figure 8.
3. Material and Methods
3.1 Photocurable resin and photoinitiator
The material selected in this work needs to have
appropriate viscosity and polymerisation characteristics
to allow it be printed successfully. Additionally, it also
needs to have vessel-like properties, such as appropriate
elasticity, biocompatibility and surface readiness for
bio-coatability. The material chosen for this study
consisted of three monomers plus a photoinitiator. The
formulations are BPA-ethoxylated-diacrylate, lauryl
acrylate and isobornylacrylate  (BLI) shown in Figure 9.
Three types of photo-initiator were tested to select the
most appropriate one that has the lowest cytotoxicity.
They are Irgacure® 184, Irgacure® 2959 and Irgacure®
369. BLI samples with three photoinitiators were
investigated by the two methods WST-1assay (three
replicates of each kind of a material; characteristic of
the sample: diameter: 14 mm, height: 1–2 mm, weight:
200 mg) and live/dead assay (characteristic of the
sample: diameter: 14 mm, height: 2–3 mm, weight:
300 mg). All samples were disinfected in 70 % ethanol
for 30 min (meanwhile the samples swelled), washed
two times for 30 min with PBS and equilibrated in cell
cell line (3T3) was used, cultured in DMEM with
glutamine (Biochrome AG, Berlin, Germany) containing
10% fetal calf serum, 50 U/mL penicillin, and 50 µg/mL
streptomycin under 5% CO2 atmosphere at 37 °C.
For  l ive/dead assay the cells  were  seeded at
25,000 cells/cm2, and after 1, 4 and 14 days, the cells
Figure 8. the design of the conical pore on the vascular vessel wall.
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on the samples were stained by adding a twofold
concentra ted solution consist ing of 30 µg/mL
International, Darmstadt, Germany). Fluorescence
staining was captured by Axiotech microscope with
filter sets FS09 and FS14 (Carl Zeiss Microscopy,
Jena, Germany). Living cells showed a bright green
fluorescence, whereas dead nuclei appeared in red.
Fluorescence micrographs from BLI samples had to
be contrasted by image processing due to the high
In the WST-1 assay, eluates from different specimens
were tested for cytotoxic components. The specimens
were eluted by incubation in complete cell culture
medium for 24 h and following periods at 37 °C.
According to ISO norm 10993-5 a volume of 1 mL
medium was applied per 0.2 g material. Eluate samples
were taken after 1, 2, 3, 6, 7, 8, 9, 10, 13, 15, 17, 21
and 24 days and the medium was completely renewed.
The elution period day 0–1, 1–2, 2–3, 6–7, 10–13 and
21–24 was finally tested.  For this 3T3 cells  have been
pre-cultured for one day in a 96 well tissue culture
plate inoculated with care with about 8,000 cells per
well. Then the medium was changed against the eluate
samples (four replicates from each eluate sample
resulting in 12 replicates representing the same material
sample) and cells were incubated with the eluates for
24 hours under cell culture conditions at 37 °C in a 5%
CO2 atmosphere. The negative control (representing no
cytotoxic influence) received pure cell culture medium
whereas the positive control (representing highest level
of cytotoxicity and complete inhibition of dehydrogenase
activities) were obtained from wells without cells
containing only culture medium. Eluate samples and
controls were changed after 24 hours against medium
with WST-1® reagent but without phenol red and
cultured for about 20 minutes to 1 hour. Formation of
coloured formazan was measured by the optical density
at 450 nm. The development of dye intensity was kept
under control to measure at a time point, when the
optical density of the negative control was between 0.2
and 0.6.  Relative dehydrogenase activity was calculated
after subtracting the mean of the positive controls by
dividing the obtained values through that of the averaged
negative controls according to . By
this procedure measured activities were placed on a scale
between 0 (positive control) and 1.0 (negative control)
or above.
3.2 AM manufacturing using stereolithography
SLA was developed in 1980’s and was one of the first
commercial AM processes [41,42]. Conventional SLA
machines have vertical resolutions in the range of
150 µm. Further developments known as “micro SLA”
can create geometries with high com plexity[43] and with
resolutions below 150 µm in all three spatial directions.
Behind the background of biomimetic structures, layer
heights of less than 10 µm, e.g. allow the replication of
capillaries that are essential for the metabolism in the
tissue. Alternative AM methods are not able to produce
such high-resolution structures[13,44,45]. The high resolution
of AM cell scaffolds or membranes enables targeted cell
alignment, cell growth and cell interaction[44,46]. The SLA
Figure 9. Three monomers in this composite
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process relies on a photo-polymerisation process and
suitable resins consist of monomers and photo-initiators
(PI) that are typically toxic. Consequently, for biomedical
applications, it is paramount to guarantee that the PI
degrades completely during the polymerisation process.
This challenge can only be overcome by interdisciplinary
process improvement, including material, SLA-process
and environmental conditions since in state-of-the-art
implementations a typical degree of polymerisation is
between 40–70% resulting in a considerable amount
of remaining PI[47]. A promising approach to guarantee
complete polymerisation and to prevent the formation
of unwanted compounds uses inert atmosphere. Only in
the absence of oxygen, it is possible to achieve complete
crosslinking and full disappearance of cytotoxic PI
and monomers. The SLA process was developed in
this work to produce the vascular network. Figure 9
illustrates the setup of the SLA process. It consists of a 3
illustrates CryLaS GmbH, Germany), a scanner system
(ProSeries PS1 Scan Heads - Cambridge Technology)
in x-y-direction. The polymer bath was positioned on a
platform connected to a piezo-axis to allow positioning
in the z-direction. For process development, different
photo resins in combination with a photo-initiator 355
nm were investigated. Detailed SLA setting is shown in
Figure 10.
3.3 Degradation test method of a printed tube
Degradation tests were carried out using dip coated
of degradation was similar to ISO 10993-13. Dip
coated tubes were prepared by dipping a mandrel with a
diameter of 1.1 mm in the BLI with Irgacure® 184 resin
and cured manually six times for a minute under an
the sample was exposed to 50% ethanol for 5 minutes,
tubes are pull up from the mandrel, dried in vacuum and
irradiated for another 5 minutes under an inert condition
with UV light. SLA fabricated tubes were prepared as
discussed in the previous section. Two groups of dip
coated samples, and two groups of SLA fabricated tubes
were treated at 36 °C in each case in PBS buffer or 3%
H2O2 for two months. The difference in weight of all
samples was determined and analysed.
3.4 In vitro testing of the vascular network
3.4.1 3.4.1. Cell Culture
Human adipose-derived stem cells (hASCs) and
pericytes were isolated from human tissue derived
from patients that underwent regular surgical treatment
and signed an informed content at the BG University
Hospital Bergmannsheil in Bochum, Germany. The
hASCs were cultured in DMEM-HAMS-F12, and the
pericytes were cultured in a pericytes-growth-medium
(PGM, PromoCell).
3.4.2 3.4.2. Cell Seeding
In the context of the study as a scaffold methacrylated
gelatin (5%; IGB) was used[5]. Using methacrylated
gelatin and a photoinitiator (LAP; INN) a stable
hydrogel was created. Within this hydrogel, three diverse
species of cells were spread: 600,000 HUVECS, 600,000
hASCs and 60,000 pericytes. In the hydrogel three
different shapes of tubes were created: 1) a stainless steel
moulded tube, 2) a single tube printed using BLI with
Irgacure® 184 and 3) a branched network printed using
BLI with Irgacure® 184.
3.4.3 3.4.3. The bioreactor system
The bioreactor system was developed in[27] driven by a
to the hydrogels. The pump was connected to a nutrient
bottle and the hydrogel containing chamber (see Figure
11). To run the bioreactor system a medium mixture was
performed in the same ratio as the corresponding cells
were distributed. The hydrogels were at least cultured
and 37°C and 5% CO2 for seven days.
3.4.4 3.4.4. Cell staining
After seven days a live/dead assay was performed
staining the hASCs with  Calcein (green)  and
Propidiumiodid (red).
Figure 10. SLA process setups.
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4. Results and Discussion
4.1 4.1. Cytotoxicity testing for photoinitiators
Firstly, in the live/dead assay, to evaluate the cytotoxic
effect observable in case of direct contact of the cells to
the material, the percentage of dead cells was determined
by manually counting live and dead cells  from
fluorescence micrographs (Figure 12). Below 5% dead
cells (during longer culture below 10%) was considered
to be not cytotoxic since this can be observed in control
cultures too. Low cytotoxicity is assumed from 5% to
20% dead cells, moderate cytotoxicity is from 20% to
50%, and high cytotoxicity is above 50%. Already the
viability staining revealed the high cytotoxicity of BLI
with Irgacure® 2959, where no viable cells could be
at BLI with Irgacure® 184 and at BLI with Irgacure® 369
developed higher cell densities from about 135–225 to
360–625 cells/mm2 during culture time and had less than
10% dead cells (Table 1).
The results of the WST-1 assays are presented in
Figure 13 as boxplot diagrams for each kind of material
and the different periods of elution. The relative
dehydrogenase activity was determined by subtraction
of the averaged blank value (identical with the positive
control) from the raw data at first, and subsequent
division of all blank corrected values by the averaged
for the metabolic rate of untreated cells). Relative
dehydrogenase activities were divided into the categories
“no, low, moderate, and high cytotoxicity” by the
separation limits  0.9, 0.75, 0.5, and < 0.5. The materials
BLI with Irgacure® 2959 and BLI with Irgacure® 369
of elution: revealing moderate to strong cytotoxicity at
day 1 and weak to moderate cytotoxicity at day 2. The
material Irgacure® 184 did not cause cytotoxicity at day
1 and a weak moderate at day 2.
BLI with Irgacure® 184 showed no to low cytotoxicity
in both live/dead and WST-1 assay. For the sample BLI
with Irgacure® 2959, very high cytotoxicity was found
in the live/dead assay. Although for the sample BLI with
Irgacure® 369 no or only low cytotoxicity was observed
in the live/dead assay, a release of cytotoxic compounds
was detected at the beginning of elution. Besides,
the data from staining could only poorly be assessed
because these samples showed a very high background
fluorescence and possibly not all cells were counted.
Therefore, BLI with Irgacure® 184 showed the best
results in both assays. Although this kind of photocured
tube material was not wholly free of cytotoxicity,
it should be well accepted in the current medical
application.
4.2 The printed vascular vessels
To define a reliable process regime, PI concentration
(0.5 wt% and 1 wt%), scan speed (5–600mm/s), layer
thickness (30µm, 100µm 150µm) and the distance
between two lines were varied. Firstly, photo resin
3D-03H-87, Marabu with 1wt% PI was used in printing
to get the best set of parameters, which were 15 kHz,
power: 10.1 mW, scan speed: 80 mm/s, line distance
30µm and a layer thickness: 800µm. Non-crosslinked
photo resin was washed away with ethanol (70%). Post-
curing with a UV-lamp was necessary. Linear tube
structures have been investigated with scanning electron
microscopy as shown in Figure 13 (A–C).
A branched vessel system was also printed from
this material using the above parameters, shown in
Figure 14 (D). It has been proven that this SLA system
can print the vascular network designed in section 2.
However, the first test material is stiff and not proven
for biocompatibility. BLI with Irgacure® 184 was then
printed for its use in stereolithography with the same
set of parameters. We could show that by using the SLA
technique, the designed branched blood vessel network
could be structured. The structure of the printed vascular
network using BLI with Irgacure® 184 with pores is
shown in Figure 15. The printing accuracy of angles
and pores was tested by flow test with dye solution.
We could demonstrate that all pores are open. In first
experiments we observed, that branching angles show
irregularities due to pores or problems from data slicing.
After correcting this a homogeneous flow through the
vessel system was observed. Long-term studies with
seeded surfaces and a blood equivalent have to be done
in later studies, to show the effect on cells.
Figure 11. The bioreactor system used for the tube supported
tissue culture. It is connected to a medium reservoir and a
peristaltic pump delivering culture media through stainless steel
moulded, a single BLI with Irgacure® 184 tubes or a branched BLI
with Irgacure® 184 tubes.
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Figure 12. Fluorescence micrographs showing representative results of viability staining of 3T3 cells cultured for one day (left column),
4 days (middle column), and 14 days (right column) at samples of the reference material glass (A–C), at BLI with Irgacure® 184 (D–F), at
BLI with Irgacure® 2959 (G–I), and at BLI with Irgacure® 369 (J–L).
A
LKJ
IHG
FED
CB
Table 1. Levels of cytotoxicity determined by live/dead staining.
Material Control (glass) BLI with Irgacure® 184 BLI with Irgacure® 2959 BLI with Irgacure® 369
Day 1 No cytotoxicity No cytotoxicity High cytotoxicity No cytotoxicity
Day 4 No cytotoxicity Low cytotoxicity; increased number
of cells from day 1 to day 4
High cytotoxicity Low cytotoxicity; increased number
of cells from day 1 to day 4
Day 14 No cytotoxicity Low cytotoxicity High cytotoxicity Low cytotoxicity
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4.3 Degradation test of a printed tube
The gravimetric analysis of the dip-coated tubes shows a
slight mass loss of approximately -1% (-1.9%) after two
months shaking in PBS buffer (H2O2 respectively) with
a standard deviation of 0.5% (1.9%). The results of the
tubes show no uniform degradation behaviour, which
would have to be expressed in a mass decrease. In some
measurements, even mass increases were observed,
which could probably be due to inclusions of PBS
salts. Overall, it is assumed that the inconsistent results
in the stereolithographic samples are due to a non-
homogeneous production method and the results show
out of not reacted monomers and inclusion effects
since we could not observe structural changes of the
samples by sight test. The more uniform results with less
scattering of the dip-coated samples show, although very
low mass loss both in the hydrolytic and oxidative cases.
So we can assume a very slow degradable material.
4.4 In vitro testing
hASCs were evaluated regarding their viability using a
live/dead assay for seven days of culture. Results of cell
viability are shown in Figure 17. Figure 17 illustrates the
cell vitality within a 1 x 1 cm hydrogel supported via a
stainless steel moulded central tube (Figure 17(A)), an
SLA-formed branched PA tube containing pores (Figure
17(B–C))  and  a  single  central  SLA-formed PA tube
containing pores (Figure 17(D)). By comparing Figure
17(A,B), it is demonstrated that the ability of a branched
tube can support the whole volume more appropriately
compared with the central steel tube. Additionally, it
is also shown that the surrounding cells get in contact
Figure
17(C)) and form more complex structures within the
hydrogel (in Figure 17(D)).
Figure 18 gives a preliminary comparison of dead cell
rate with different embedded tubes. It can be seen from
this picture that after seven days, cell death rate in the
Figure 13. Results of the WST-1 assays. The Box-whisker-plots indicate the median in the centre of the box, 25th and 75th percentile by
the lower and upper margin of the box, 10th and 90th percentile by the whiskers and values outside this range.
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Figure 14. Structures of the linear tube in different scales (A to C) and the structure of the branched tube (D).
Figure 15. the structures of the printed branched vessel network using BLI with Irgacure® 184 with pores.
Figure 16. Blot-Plot results from gravimetric study dip-coated tubes (DIP) and fabricated by SLA (Stereo) to observe hydrolytic
degradation in PBS buffer (pH = 7.4) and oxidative degradation in 3% H2O2.
A B
A B
C D
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branched vessel is the lowest (27%) compared with the
pure hydrogel (35%) and hydrogel with a single tube
(55%).
The pure hydrogel used as a scaffold in this work has
proven to be non-toxic and has a good biocompatibility.
This can also be seen in Figure 18 that the pure hydrogel
scaffold has less than 50% percent cell death rate
after seven days. The curable resin made of BLI with
Irgacure® 184 was proven to be biocompatible and
cytocompatible among other photopolymers used in
the previous testing in section. However, when a single
tube was embedded in the scaffold, the cell death rate
increased after seven days compared with the pure
hydrogel scaffold. This may be a reason for sub-optimal
nutrient supply. The cell death rate was decreased
significantly by embedding an optimised branched
vascular vessel network into the scaffold. It shows a
sharp drop (from 55% to 27%) of the cell death rate.
This testing indicates that using the optimised vascular
network, cells viability may be improved by having a
better oxygen and nutrient supply from the bioreactor.
Further investigations are needed to determine the long-
term cell survival and the further behaviour of the cells
in the bioreactor system.
5. Conclusion and Future Work
In this paper, an optimised vascular network was
developed using a set of comprehensive design rules.
These design rules considered the physiological
requirements in both macro- and micro-scales. The
optimised vascular network has several advantages:
1) this design provides the maximum nutrient supply
with minimal complexity; 2) this design minimises the
recirculation areas and 3) this design allows the WSS
on the vessel in a healthy range. Suitable photo-curable
resin with photoinitiators was then selected based on the
WST-1 assays and live/dead assays. The results show
that BLI with Irgacure® 184 has the lowest cytotoxicity
among three and it is the best candidate used in SLA for
printing the design.  Preliminary in vitro studies were
into an adipose tissue scaffold. The in vitro study only
has two tested time steps, and the results show that
branched resin made vascular network has the lowest
cell death rate compared with the pure hydrogel scaffold
and the hydrogel scaffold embedded with a single
tube. The design and manufacturing route for vascular
vessels developed in this paper proven to be feasible
Figure 17. Cell vitality within a 1 x 1 cm hydrogel supported via (A) a stainless steel moulded central tube; (B,C) a branched BLI with
Irgacure® 184 tube containing pores; (D) single central SLA-formed BLI with Irgacure® 184 tube containing pores.
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and have potentials to be further developed. Plan of
the future work following this paper will be, 1) more
in vitro experiments need to be carried out in order to
validate the design; 2) in the current skin model, they
surrounding hydrogel is biodegradable which allowing
remodelling in vivo. Currently, the material (BLI) used
to manufacture the vascular network is none or very
slow degradable according to the degradation analysis.
The biodegradable polymer will be used to manufacture
the vascular network allowing remodelling; 3) top skin
layers (epidermis and dermis) will be added to the skin
model as complete skin integration.
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